![](/img/cover-not-exists.png)
Phase I Trial of Sorafenib in Combination with IFN -2a in Patients with Unresectable and/or Metastatic Renal Cell Carcinoma or Malignant Melanoma
Escudier, B., Lassau, N., Angevin, E., Soria, J. C., Chami, L., Lamuraglia, M., Zafarana, E., Landreau, V., Schwartz, B., Brendel, E., Armand, J.-P., Robert, C.Volume:
13
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-06-1432
Date:
March, 2007
File:
PDF, 476 KB
english, 2007